Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of NR5A1 mRNA] | affects expression|affects reaction | 19414516
|
C003585 |
22-hydroxycholesterol |
22-hydroxycholesterol promotes the reaction [NR5A1 protein results in increased expression of STAR protein] | increases expression|increases reaction | 9804848
|
C007997 |
25-hydroxycholesterol |
25-hydroxycholesterol promotes the reaction [NR5A1 protein results in increased expression of STAR protein] | increases expression|increases reaction | 9804848
|
C007997 |
25-hydroxycholesterol |
25-hydroxycholesterol results in increased activity of NR5A1 protein | increases activity | 9144161
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol promotes the reaction [NR5A1 protein results in increased expression of STAR protein] | increases expression|increases reaction | 9804848
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol results in increased activity of NR5A1 protein | increases activity | 9144161
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of NR5A1 mRNA | decreases expression | 16788091
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NR5A1 mRNA | affects expression | 16483693
|
D001280 |
Atrazine |
Atrazine binds to NR5A1 protein | affects binding | 17520059
|
D001280 |
Atrazine |
Atrazine promotes the reaction [[NR5A1 protein binds to CYP19A1 gene] which results in increased expression of CYP19A1 mRNA] | affects binding|increases expression|increases reaction | 17520059
|
D001280 |
Atrazine |
Atrazine results in increased expression of NR5A1 mRNA | increases expression | 17520059
|
D001280 |
Atrazine |
Atrazine results in increased expression of NR5A1 protein | increases expression | 17520059
|
D001280 |
Atrazine |
Atrazine results in increased phosphorylation of NR5A1 protein | increases phosphorylation | 18461179
|
D001280 |
Atrazine |
NR5A1 protein affects the reaction [Atrazine results in increased expression of CYP19A1 mRNA] | affects reaction|increases expression | 18461179
|
D001280 |
Atrazine |
NR5A1 protein affects the reaction [Atrazine results in increased expression of LHB mRNA] | affects reaction|increases expression | 18461179
|
D001280 |
Atrazine |
NR5A1 protein promotes the reaction [Atrazine results in increased expression of CYP11A1 mRNA] | increases expression|increases reaction | 18461179
|
D001280 |
Atrazine |
NR5A1 protein promotes the reaction [Atrazine results in increased expression of HSD11B2 mRNA] | increases expression|increases reaction | 18461179
|
D001280 |
Atrazine |
NR5A1 protein promotes the reaction [Atrazine results in increased expression of INHA mRNA] | increases expression|increases reaction | 18461179
|
D001280 |
Atrazine |
NR5A1 protein promotes the reaction [Atrazine results in increased expression of STAR mRNA] | increases expression|increases reaction | 18461179
|
D001280 |
Atrazine |
Atrazine results in increased activity of NR5A1 protein | increases activity | 18461179
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of NR5A1 mRNA | increases expression | 17520059
|
C014347 |
decitabine |
decitabine affects the methylation of NR5A1 promoter | affects methylation | 17519303
|
D003994 |
Bucladesine |
Bucladesine inhibits the reaction [CTBP1 protein binds to NR5A1 protein] | affects binding|decreases reaction | 18184656
|
D003633 |
Dichlorodiphenyl Dichloroethylene |
Dichlorodiphenyl Dichloroethylene affects the expression of NR5A1 mRNA | affects expression | 16707152
|
D004026 |
Dieldrin |
Dieldrin affects the expression of NR5A1 mRNA | affects expression | 16707152
|
D004051 |
Diethylhexyl Phthalate |
Diethylhexyl Phthalate results in decreased expression of NR5A1 mRNA | decreases expression | 16690193
|
D004958 |
Estradiol |
Estradiol results in increased activity of NR5A1 protein | increases activity | 19549922
|
D004958 |
Estradiol |
U 0126 inhibits the reaction [Estradiol results in increased activity of NR5A1 protein] | decreases reaction|increases activity | 19549922
|
D004958 |
Estradiol |
wortmannin inhibits the reaction [Estradiol results in increased activity of NR5A1 protein] | decreases reaction|increases activity | 19549922
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NR5A1 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of NR5A1 mRNA | decreases expression | 17222921
|
D005485 |
Flutamide |
Flutamide results in decreased expression of NR5A1 mRNA | decreases expression | 17222921
|
C516216 |
GSK 8470 |
GSK 8470 binds to and results in increased activity of NR5A1 protein | affects binding|increases activity | 17154495
|
D019289 |
Pyruvic Acid |
Pyruvic Acid inhibits the reaction [CTBP1 protein binds to NR5A1 protein] | affects binding|decreases reaction | 18184656
|
D019289 |
Pyruvic Acid |
Pyruvic Acid promotes the reaction [NR5A1 protein binds to CYP17A1 promoter] | affects binding|increases reaction | 18184656
|
D012839 |
Simazine |
Simazine results in increased expression of NR5A1 mRNA | increases expression | 17520059
|
D014284 |
Triiodothyronine |
Triiodothyronine affects the expression of NR5A1 mRNA | affects expression | 17403546
|
D013629 |
Tamoxifen |
Tamoxifen analog results in increased activity of NR5A1 protein | increases activity | 19549922
|
D013629 |
Tamoxifen |
Tamoxifen analog results in increased phosphorylation of NR5A1 protein | increases phosphorylation | 19549922
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NR5A1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NR5A1 mRNA | decreases expression | 16254025
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of NR5A1 mRNA | decreases expression | 16604517 16788091
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [Estradiol results in increased activity of NR5A1 protein] | decreases reaction|increases activity | 19549922
|
C025643 |
vinclozolin |
vinclozolin results in decreased expression of NR5A1 mRNA | decreases expression | 18042343
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [Estradiol results in increased activity of NR5A1 protein] | decreases reaction|increases activity | 19549922
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
OMIM:612965 |
46,XY SEX REVERSAL 3 |
marker/mechanism |
|
| |
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.34 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Diethylhexyl Phthalate |
8.01 | 6734493 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.01 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.35 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.73 | 17505938 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
5.26 | 17694057 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.68 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.68 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.68 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.53 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.17 | 16835633 |
MESH:D000309 |
Adrenal Insufficiency |
marker/mechanism |
|
| |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
13.60 | 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Dichlorodiphenyl Dichloroethylene |
13.60 | 16487989 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Simazine |
13.60 | 12661182 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.45 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
27-hydroxycholesterol |
3.68 | 14523054 20157255 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.76 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.48 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.87 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.26 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.78 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.78 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.22 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.28 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
27-hydroxycholesterol |
4.31 | 11166758 9059518 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.20 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.31 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.31 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.58 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.63 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.56 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
4.56 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Dichlorodiphenyl Dichloroethylene |
4.56 | 15061365 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
4.56 | 11859874 15770527 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.56 | 19861407 17289903 17018787 12948864 14630087 16675129 18497071 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.56 | 20390343 19142967 16273361 18351453 18984771 19011961 20005174 18815881 19059307 16202921 19244106 19084267 20065188 19189212 21152245 19155303 17242785 17440819 19103187 15668708 17261762 16873071 21138602 20859285 19288272 20544844 18997820 19189210 19200415 17893378 20135344 15565566 19289846 19221464 11161223 18855134 18821012 18629630 19410462 19115204 19487384 16818667 19066611 18425577 17049068 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.56 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.56 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.38 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.25 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.63 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.30 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.95 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.39 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.39 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.39 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.17 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.17 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.17 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.43 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.25 | 16120746 18670907 18850075 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.97 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.63 | 18566989 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.38 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.72 | 17333356 17681005 15861022 16105132 11677210 16919318 17110522 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.95 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.47 | 15668235 16354765 12621046 8697196 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.47 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.50 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.30 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.88 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.38 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.38 | 9224671 17551590 8800419 10589399 9664655 16925845 9211117 14991402 9125849 9142499 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.14 | 14966744 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.15 | 19031437 |
MESH:D003715 |
Dengue |
|
27-hydroxycholesterol |
5.47 | 19427377 |
MESH:D003876 |
Dermatitis, Atopic |
|
Diethylhexyl Phthalate |
3.95 | 16882537 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.62 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.25 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.25 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.48 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.61 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Dichlorodiphenyl Dichloroethylene |
5.05 | 16487989 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.20 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.23 | 18230668 16714409 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.23 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
27-hydroxycholesterol |
14.34 | 17410599 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
14.34 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
14.34 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.90 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
11.64 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
11.64 | 19155303 16202921 17893378 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.64 | 16569247 |
MESH:D004715 |
Endometriosis |
marker/mechanism |
|
| 17519303 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.84 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.96 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.32 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.32 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.07 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
7.07 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.11 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.25 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.32 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.97 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.93 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
7.93 | 17994277 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.72 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.09 | 16417039 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.87 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.38 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.37 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.37 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.95 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.46 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.46 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.46 | 9664655 14991402 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.15 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Dichlorodiphenyl Dichloroethylene |
4.84 | 16487989 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.69 | 12621046 16120746 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.82 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.54 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.83 | 8697196 16354765 15340226 18606429 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.05 | 16870215 |
MESH:D017588 |
Hyperandrogenism |
|
Flutamide |
5.25 | 15356085 |
MESH:D006937 |
Hypercholesterolemia |
|
27-hydroxycholesterol |
4.97 | 17873880 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.36 | 16778211 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.83 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.60 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
9.64 | 10630421 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
9.64 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
19.67 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
19.67 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Dichlorodiphenyl Dichloroethylene |
19.67 | 12948891 17192596 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
19.67 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
19.67 | 16467254 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.53 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.53 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.83 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.56 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.30 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.30 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.47 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.82 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
6.82 | 18625569 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.08 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.08 | 17143497 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
5.10 | 16972261 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
8.93 | 19117987 18454857 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.93 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.84 | 18460780 19010910 18704418 19387464 18206229 17679729 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.84 | 19850784 17596541 16294345 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.25 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.02 | 19035177 16766008 17339181 16331271 19642359 19225113 17107899 17368321 17361223 9834237 17294898 17217047 16823087 17506722 17649720 15748426 19075265 16140955 17301526 12679006 16788101 17712046 16891316 19029980 16935935 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.52 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Dichlorodiphenyl Dichloroethylene |
8.15 | 12745335 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
8.15 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.01 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.72 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.72 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.72 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.72 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
13.42 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
13.42 | 9539021 8742319 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylhexyl Phthalate |
13.42 | 11940454 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
13.42 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.42 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
1.98 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.20 | 17053015 20064080 18520028 20135361 20869020 20464547 18816296 18569708 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.20 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.20 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.27 | 19470736 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.55 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.53 | 11408345 11807958 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.53 | 16827153 11731420 19196722 14580682 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.94 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.94 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.70 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
4.90 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.90 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.90 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.97 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.22 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.45 | 1916698 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.03 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.20 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.08 | 19010910 16882708 19157545 18608210 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.08 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.85 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.12 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.46 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.45 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
11.07 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
11.07 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
11.07 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.07 | 16946489 16594593 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.79 | 19196722 19200415 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.52 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.16 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.16 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.16 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
2.92 | 9142499 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
10.79 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.79 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
10.79 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
10.79 | 16211241 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.74 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.12 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.12 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.49 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
5.69 | 17218051 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
5.69 | 16809432 17291500 16112328 11181820 11445065 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.04 | 12520081 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Flutamide |
4.82 | 15356085 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.36 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.79 | 11399792 11118676 11896295 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
8.79 | 18042343 18220299 19015723 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.52 | 17616702 |
MESH:D016649 |
Primary Ovarian Insufficiency |
marker/mechanism |
|
| |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.72 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.69 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.92 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.92 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flutamide |
1.92 | 3169114 |
MESH:D011471 |
Prostatic Neoplasms |
|
Simazine |
1.92 | 12661182 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.92 | 15067354 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.72 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.41 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.10 | 15861022 16919318 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.58 | 16723453 |
MESH:D011649 |
Pulmonary Alveolar Proteinosis |
|
27-hydroxycholesterol |
6.18 | 15466366 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
4.31 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.64 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.30 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.30 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
8.81 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.81 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
8.81 | 16467112 |
MESH:D019082 |
Smith-Lemli-Opitz Syndrome |
|
27-hydroxycholesterol |
5.81 | 11254748 |
OMIM:270800 |
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE |
|
27-hydroxycholesterol |
6.16 | 19812052 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.85 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.85 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.83 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.26 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.26 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.26 | 17261132 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.42 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.98 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.69 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
6.77 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
6.77 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.47 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.60 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.10 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
7.85 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
7.85 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
7.85 | 16712894 8653321 17572228 |
MESH:D014570 |
Urologic Diseases |
|
Dichlorodiphenyl Dichloroethylene |
5.53 | 16487989 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.49 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.10 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
12.12 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
12.12 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.38 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.35 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.85 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.04 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.79 | 16287080 |